retatrutide nonalcoholic fatty liver disease nash trial A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis Nonalcoholic Fatty Liver Disease in
Pay in 4 interest-free payments of $5.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

























